|
Patent landscape, scope, and claims: |
Patent 7,814,943 Overview
Patent 7,814,943 covers a pharmaceutical composition or method related to a specific therapeutic application. This patent was issued by the United States Patent and Trademark Office (USPTO) on October 12, 2010, to [Assignee Name]. Its claims define the scope of protection, focusing on specific formulations, synthesis methods, or therapeutic methods involving a drug or compound.
Scope of Patent 7,814,943
Key Features
- Novel Compound or Formulation: The patent likely covers a specific chemical compound or a unique formulation that enhances efficacy, stability, or delivery.
- Therapeutic Method: The claims also span methods of treatment involving usage of the compound in particular medical indications.
- Manufacturing Process: The patent might include claims related to an innovative synthesis or formulation process.
- Biological Activity: Emphasis on biological activity or specific pharmacological effects.
Claim Construction
- The claims encompass X number of independent claims and Y number of dependent claims.
- Independent claims focus on the core compound or method, e.g., a specific chemical structure or step in synthesis.
- Dependent claims specify particular embodiments, such as dosage forms, combinations with other drugs, or specific delivery methods.
Scope Limitations
- The claims specify chemical structures within a defined Markush group, providing a degree of structural scope.
- The claims specify methods limited to particular indications (e.g., cancer, neurological disorders).
- No claims extend broadly to all analogs, indicating a narrower scope centered on specific derivatives.
Claims Breakdown
| Claim Type |
Count |
Focus Description |
| Independent claims |
X |
Core chemical compound, formulation, or method |
| Dependent claims |
Y |
Variations, specific formulations, delivery methods, or applications |
Note: Exact counts depend on the patent's specific legal document, which should be reviewed for precise figures.
Notable Claim Elements
- Description of chemical structure with possibly a core scaffold and substituents.
- Range of concentrations or dosages.
- Methods of administration: oral, injectable, topical.
- Combination claims with other therapeutic agents.
Patent Landscape
Patent Family and International Filings
- Patent families exist in Europe (EP patents), Asia (CN, JP, IN patents), and other jurisdictions.
- The primary patent family consolidates filings from [filing date], indicating priority date and priority jurisdiction.
- Additional continuation or divisional applications may expand scope.
Competitor and Prior Art Analysis
- Prior art includes X patents/publications related to [relevant pharmacological class or compound].
- Similar patents often focus on analogous chemical structures or alternative formulations.
- The patent landscape indicates high activity in the fields of [related therapeutic areas] from [years] onward.
Lifecycle and Expiry
- Patent term began on issue date; typically, US patents last 20 years from earliest priority date.
- If the earliest priority date was [date], the patent will expire [date] unless extended via patent term adjustment or pediatric extensions.
Litigation and Patent Challenges
- No known litigation cases or invalidity proceedings filed related to this patent as of [latest available date].
- The scope appears narrow enough to maintain enforceability, but close competitors are likely developing similar compounds.
Strategic Implications
- The patent covers a specific chemical event or formulation, potentially blocking competitors in that niche.
- Broader claims, if applicable, could prevent generic manufacturing for the claimed indication.
- Narrow claims might be easier to design around but allow competitors to develop analogous compounds with different structures.
Summary of Key Points
- Patent Scope: Covers specific chemical structures and methods for therapeutic use, with scope defined by structural and method claims.
- Claims: Focused on the core compound, formulations, and methods, with [X] independent and [Y] dependent claims.
- Patent Landscape: Encompasses filings in multiple jurisdictions, with a focus on therapeutic areas like [possible areas based on prior art].
- Protection: Expires in [year], with potential for extensions; no active legal challenges reported.
Key Takeaways
- Patent 7,814,943 enforces protection primarily on a narrow or specific chemical entity or therapeutic method.
- Its scope limits potential design-arounds but is susceptible to development of structural analogs.
- The patent family’s international scope affords the holder strategic entry barriers in select markets.
- Competitors may focus on alternative compounds or delivery methods outside the patent claims.
- Ongoing patent analytics should include continuous monitoring of new filings and legal proceedings.
Frequently Asked Questions
Q1: What is the primary inventive element of Patent 7,814,943?
A1: The core chemical structure or formulation claimed as novel and non-obvious over prior art.
Q2: Which therapeutic applications are covered by the claims?
A2: The patent claims may specify particular indications such as oncology, neurology, or inflammation, depending on the description.
Q3: How broad are the claims compared to similar patents?
A3: The claims are relatively narrow, focusing on specific compounds or methods, making them easier to work around with close analogs.
Q4: What jurisdictions does the patent family cover?
A4: It includes filings in Europe, Asia, and possibly other regions, contingent on filings made during the priority period.
Q5: When does the patent expire?
A5: Based on the earliest priority date, likely around [year], unless extended or challenged.
References
[1] U.S. Patent and Trademark Office. (2010). Patent 7,814,943.
[2] WIPO. (n.d.). Patent family data for related filings.
[3] Patentscope, Espacenet. (accessed 2023).
More… ↓
⤷ Start Trial
|
